Clinical trials: Placenta Previa With Hemorrhage - Delivered
Placenta Previa With Hemorrhage - Delivered, Placenta Accreta
A.Chohan Continuous Squeezing Suture (ACCSS) for Placenta Previa / Accreta
Placenta praevia and accreta spectrum disorders are rising in incidence due to increased rate of repeat caesarean sections. Peripartum hysterectomy remains the only definitive treatment of massive postpartum haemorrhage related…
- Trial name
- ACCSS (NCT04660578)
- Testing
- ACCSS
- Where
- Pakistan
- Volunteers
- 30 people
- Sponsor
- King Edward Medical University
Hemorrhage From Placenta Previa, With Delivery
Role of Prophylactic Tranexamic Acid in Reducing Blood Loss During Elective Caesarean Section for Placenta Praevia Major
Prophylactic tranexamic acid will reduce blood loss during Caesarean section for placenta praevia
- Trial name
- NCT04350645
- Testing
- Tranexamic acid injection, Normal Saline 0.9%
- Where
- Malaysia
- Volunteers
- 30 people
- Sponsor
- Universiti Kebangsaan Malaysia Medical Centre
Placenta Previa, Placenta Accreta Spectrum
Planned Delivery at 37 Versus 36 Weeks in Pregnancies With Placenta Previaand Accreta
Current clinical practice guidelines recommend planned cesarean delivery(CD) at 34-37 weeks of gestation in pregnant women with placenta previa and accreta.
- Conditions
- Placenta Previa, Placenta Accreta Spectrum, Antepartum Bleeding, Emergency Cesarean Section
- Trial name
- NCT07025954
- Testing
- Cesarean delivery
- Where
- 6 sites in China
- Volunteers
- 600 people
- Sponsor
- The Third Affiliated Hospital of Guangzhou Medical University
Placenta Previa
17-Alpha-Hydroxyprogesterone Caproate in Pregnant Women With Placenta Previa
Purpose to evaluate the effects of intramuscular 17-Alpha-Hydroxyprogesterone Caproate (17-OHPC) for prevention of Emergent Cesarean Delivery in symptomatic Pregnant Women with Placenta Previa
- Trial name
- NCT03779438
- Testing
- 17-OHPC
- Where
- Egypt
- Volunteers
- 300 people
- Sponsor
- Aswan University Hospital
Placenta Previa
Efficacy of Topical Tranexamic Acid in Reducing Blood Loss During CS in Patients With Placenta Previa
Objectives: To evaluate the efficacy of topical tranexamic acid applied on the placental bed after placental delivery to reduce blood loss during cesarean delivery in women with placenta previa.
- Trial name
- NCT06515535
- Testing
- Topical tranexamic acid, Intravenous tranexamic acid
- Volunteers
- 56 people, healthy volunteers welcome
- Sponsor
- Cairo University
Postpartum Hemorrhage
TRAnexamic Acid for Preventing Blood Loss Following a Cesarean Delivery in Women With Placenta pREVIA
Several randomized, controlled trials, mostly involving women undergoing cesarean delivery, have shown that the prophylactic intravenous administration of 1 g of tranexamic acid after childbirth reduced blood loss.
- Trial name
- TRAAPrevia (NCT04304625)
- Testing
- Tranexamic Acid / Sodium chloride
- Where
- France
- Volunteers
- 1,380 people
- Sponsor
- University Hospital, Bordeaux
Placenta Previa
Blood Loss During Cesarean Delivery in Placenta Previa Patients
To compare the efficacy and safety profile of intravenous tranexamic acid versus intrauterine misoprostol in reducing the blood loss during and after cesarean delivery in pregnant women diagnosed with placenta previa
- Trial name
- NCT05340205
- Testing
- Tranexamic acid, Misoprostol, Oxytocin
- Where
- Egypt
- Volunteers
- 81 people, healthy volunteers welcome
- Sponsor
- Cairo University
Placenta Previa
Vaginal Progesterone Versus 17-Alpha-Hydroxyprogesterone Caproate in Placenta Previa
Purpose to evaluate the effects of Vaginal Progesterone versus 17-Alpha-Hydroxyprogesterone Caproate for prevention of Emergent Cesarean Delivery in Asymptomatic Pregnant Women with Placenta Previa
- Trial name
- NCT03779451
- Testing
- 17-OHPC, vaginal progesterone
- Where
- Egypt
- Volunteers
- 400 people
- Sponsor
- Aswan University Hospital